A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

S. B. Cohen, L. W. Moreland, J. J. Cush, M. W. Greenwald, S. Block, W. J. Shergy, P. S. Hanrahan, M. M. Khraishi, A. Patel, G. Sun, M. B. Bear

Research output: Contribution to journalArticlepeer-review

237 Scopus citations

Fingerprint Dive into the research topics of 'A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds